Clinical Trials on Coronavirus Antibody Levels in Japan
Total 86 results
-
Showa Inan General HospitalRecruiting
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisJapan
-
Mitsubishi Tanabe Pharma CorporationRecruitingAntineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)Japan
-
GlaxoSmithKlineActive, not recruiting
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Canada, United States, Korea, Republic of, Australia, Japan, Italy, Brazil, Germany, France, China, Israel
-
ModernaTX, Inc.CompletedCoronavirus Disease (COVID-19)Japan
-
UCB Biopharma SRLRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)United States, Australia, Belgium, Czechia, France, Germany, Italy, Japan, Korea, Republic of, Mexico, Spain, Sweden, Switzerland, Turkey, Portugal, United Kingdom, Brazil, Ukraine, Taiwan
-
TakedaWithdrawnSurvey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 SymptomsCoronavirus Disease (COVID-19)Japan
-
TakedaCompleted
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
TakedaCompletedCoronavirus Disease (COVID-19)Japan
-
Osaka UniversityMerck Sharp & Dohme LLCUnknownHyper-LDL-cholesterolemia | Low CETP Activity | CETP Deficiency | Hyperalphalipoproteinemia | High Level of Remnant CholesterolJapan
-
AstraZenecaCompleted
-
PfizerCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
Genova Inc.Tokyo Shinagawa HospitalRecruiting
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2Japan
-
PfizerCompletedSARS-CoV-2 InfectionJapan
-
Daiichi Sankyo Co., Ltd.Completed
-
Kitasato UniversityActive, not recruiting
-
Bristol-Myers SquibbCompleted
-
Humanity & Health Medical Group LimitedTokyo University; Nihon University School of MedicineRecruiting
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
AstraZenecaTerminatedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
GlaxoSmithKlineActive, not recruiting
-
MedicagoMitsubishi Tanabe Pharma CorporationTerminated
-
AstraZenecaIqvia Pty LtdCompleted
-
Chiba UniversityActive, not recruitingMicroscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener GranulomatosisJapan
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompletedCOVID-19 Lower Respiratory InfectionJapan
-
AstraZenecaCompletedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
U.S. Army Medical Research and Development CommandNo longer availableCoronavirus Disease 2019United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
U.S. Army Medical Research and Development CommandNo longer availableTreatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)Severe Acute Respiratory Syndrome Coronavirus 2United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
Novartis PharmaceuticalsCompletedPeriodic Fevers SyndromeJapan
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.RecruitingChurg-Strauss Syndrome | Eosinophilic Granulomatosis With PolyangiitisUnited States, Japan
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
Experimental and Clinical Research Center, a cooperation...RecruitingMultiple Sclerosis | Demyelinating Diseases | Optic Neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseItaly, United States, Argentina, Australia, Botswana, Brazil, Colombia, Denmark, France, Germany, India, Israel, Japan, Korea, Republic of, Spain, United Kingdom, Zambia
-
Merck Sharp & Dohme LLCCompletedCoronavirus Disease (COVID-19)United States, Argentina, Brazil, Bulgaria, Colombia, Dominican Republic, Egypt, France, Guatemala, Hungary, Japan, Kenya, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, South Africa, Spain, Thailand, Turkey, Ukraine
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium
-
National Center for Global Health and Medicine,...Active, not recruitingCovid19 | Urine | Acute Respiratory Failure With Hypoxia | BiomarkerUnited States, Brazil, Denmark, Japan, Philippines